实验方案(Protocols)

Recombinant Human CA5A Protein: Handling & Usage Protocol

Recombinant Human CA5A Protein is a mitochondrially localized carbonic anhydrase isoform produced recombinantly for use in enzymatic activity assays, structural studies, inhibitor screening, and related biochemical research applications.

Protein Name
Recombinant Human CA5A (Carbonic Anhydrase VA) Protein
Gene / Aliases
CA5A; CA-VA; Carbonic anhydrase 5A, mitochondrial
Biological Function
Catalyzes the reversible hydration of CO₂ to bicarbonate and a proton, supporting mitochondrial metabolic processes including gluconeogenesis, ureagenesis, and lipogenesis
Expression System
Recombinant expression system (specific host system to be confirmed with Certificate of Analysis)
SKU / Catalog Number
rp365592
Recommended Storage
Store at -20°C or -80°C upon receipt; avoid repeated freeze-thaw cycles. Refer to the product datasheet for specific buffer and storage conditions.
Application Areas
Enzymatic activity assays, inhibitor screening, Western blot, ELISA, structural biology, and metabolic pathway research

Background and Biological Significance of CA5A

Carbonic anhydrase 5A (CA5A), also designated CA-VA, is a member of the alpha-carbonic anhydrase family and is uniquely localized to the mitochondrial matrix. The enzyme catalyzes the reversible hydration of carbon dioxide (CO₂ + H₂O ⇌ HCO₃⁻ + H⁺), a reaction fundamental to pH regulation, ion transport, and the supply of bicarbonate as a substrate for carboxylation reactions.

Within the mitochondrial matrix, CA5A plays a pivotal role in supporting anaplerotic and biosynthetic pathways, including gluconeogenesis, ureagenesis, and de novo lipogenesis—all of which depend on bicarbonate as a co-substrate for carboxylases such as pyruvate carboxylase and carbamoyl phosphate synthetase I. Dysregulation of CA5A activity has been linked to metabolic disorders, making it a relevant target for pharmacological inhibition studies.

Recombinant Human CA5A Protein provides researchers with a well-characterized, research-grade reagent to investigate the enzyme's catalytic mechanism, screen for selective inhibitors (e.g., sulfonamide-based compounds), or explore its structural biology.

Materials and Equipment Required

Before beginning the protocol, ensure the following materials and equipment are available:

  • Recombinant Human CA5A Protein (Aladdin Scientific, SKU: rp365592)
  • Appropriate reconstitution buffer as specified on the product Certificate of Analysis (CoA) or datasheet (typically sterile PBS or Tris-HCl-based buffer, pH 7.4)
  • Sterile, nuclease-free water or buffer for dilution
  • Low-binding microcentrifuge tubes (1.5 mL or 0.5 mL)
  • Micropipettes and calibrated tips
  • Microcentrifuge capable of ≥10,000 × g
  • Dry ice or liquid nitrogen for snap-freezing aliquots
  • -20°C and/or -80°C freezers
  • Ice bucket with ice
  • Relevant assay reagents (e.g., CO₂/bicarbonate substrates for activity assay, or ELISA/Western blot reagents for detection applications)

Note: Always consult the product-specific datasheet and CoA included with shipment for the most accurate and up-to-date specifications.

Step-by-Step Protocol: Reconstitution, Aliquoting, and Storage

Step 1 — Thawing the protein
Remove the vial from -80°C (or -20°C) storage and allow it to thaw slowly on ice at 4°C for 15–30 minutes. Do not thaw at room temperature or use a water bath, as rapid temperature changes may cause aggregation or loss of activity.

Step 2 — Brief centrifugation
Once thawed, briefly centrifuge the vial (1,000–2,000 × g, 30 seconds) to consolidate the liquid and any material that may have adhered to the cap or walls during freeze-drying or shipping.

Step 3 — Reconstitution (lyophilized product)
If the product is supplied in lyophilized form, add the reconstitution buffer recommended on the datasheet slowly along the side of the vial. Gently swirl or pipette up and down; do not vortex. Allow the protein to dissolve for 5–10 minutes on ice before proceeding.

Step 4 — Determine protein concentration
Measure the protein concentration using an appropriate method (e.g., BCA assay, Bradford assay, or absorbance at A₂₈₀) and compare to the nominal concentration stated on the CoA. Adjust with buffer if necessary.

Step 5 — Prepare single-use aliquots
Divide the reconstituted protein into single-use aliquots in low-binding microcentrifuge tubes to minimize freeze-thaw cycling. Snap-freeze aliquots in liquid nitrogen or on dry ice immediately.

Step 6 — Storage
Store aliquots at -80°C for long-term storage (typically up to 12 months) or at -20°C for short-term storage (up to 1 month). Once thawed, keep on ice and use within the same working session. Discard unused thawed protein; do not re-freeze.

All time and temperature parameters are general best-practice guidelines. Always verify against the product-specific CoA and datasheet.

Application Guidelines for CA5A Research Assays

Enzymatic Activity Assay: CA5A activity can be measured using the stopped-flow CO₂ hydration assay or colorimetric p-nitrophenyl acetate (pNPA) esterase assay. Prepare the enzyme in the appropriate assay buffer (consult literature for validated buffer conditions and pH, typically pH 7.0–7.5 for carbonic anhydrase assays). Use the minimum effective enzyme concentration to limit substrate depletion artifacts.

Inhibitor Screening: Recombinant CA5A is suitable for in vitro inhibitor profiling. Pre-incubate the protein with test compounds (e.g., sulfonamides, coumarin derivatives) for 15–30 minutes at room temperature before initiating the reaction. Include positive controls (e.g., acetazolamide as a pan-CA inhibitor) and negative controls (vehicle only) in each assay plate.

Western Blot: Use 0.1–1 µg of Recombinant Human CA5A Protein per lane as a positive control. Separate by SDS-PAGE under reducing conditions. Validate the anti-CA5A primary antibody specificity using this recombinant standard.

ELISA: The recombinant protein can serve as a coating antigen or standard curve reference. Optimize coating concentration (typically 0.1–2 µg/mL) empirically for each assay format.

Working concentrations for all assay types should be optimized in each laboratory setting. The above ranges are provided as starting points only.

Troubleshooting Guide

ProblemPossible CauseRecommended Action
No or low enzymatic activityProtein denatured due to improper thawing or repeated freeze-thaw cyclesUse freshly thawed single-use aliquots; ensure slow thaw on ice; verify protein concentration
Protein aggregation or precipitationIncorrect buffer composition, excessive concentration, or freeze-thaw damageCentrifuge (10,000 × g, 5 min, 4°C) to remove aggregates; dilute protein; use low-binding tubes
High background in ELISA or WBNon-specific binding or excessive coating concentrationOptimize blocking conditions; reduce protein concentration; include appropriate controls
Inconsistent assay resultsPipetting error, protein adsorption to tube surfaces, or expired reagentsUse low-binding tubes; calibrate pipettes; prepare fresh substrate solutions; check reagent expiry

If problems persist after following these troubleshooting steps, contact Aladdin Scientific technical support with your lot number and CoA details.

Frequently asked questions

What is the recommended reconstitution buffer for Recombinant Human CA5A Protein?

The recommended reconstitution buffer is specified on the product-specific Certificate of Analysis (CoA) and datasheet included with each shipment. A common starting point for recombinant proteins is sterile phosphate-buffered saline (PBS, pH 7.4) containing a carrier protein such as 0.1% BSA to enhance stability, but always defer to the product CoA for the exact formulation.

How many freeze-thaw cycles can Recombinant Human CA5A Protein tolerate?

As with most recombinant proteins, repeated freeze-thaw cycles are a common cause of activity loss and aggregation. It is strongly recommended to prepare single-use aliquots upon first thaw and to limit freeze-thaw cycles to a maximum of two to three. Discard any aliquots that have been thawed and not used within the same working session.

Is Recombinant Human CA5A Protein suitable for inhibitor screening assays?

Yes, Recombinant Human CA5A Protein is well-suited for in vitro inhibitor screening, including profiling of sulfonamide-based carbonic anhydrase inhibitors. Pre-incubate the protein with the test compound before initiating the enzymatic reaction, and always include appropriate positive (e.g., acetazolamide) and negative (vehicle) controls to validate assay performance.

What expression system is used to produce Recombinant Human CA5A Protein?

The specific expression system (e.g., E. coli, baculovirus/insect cells, HEK293, or CHO) for this recombinant protein should be confirmed by reviewing the product CoA and datasheet provided by Aladdin Scientific (SKU: rp365592), as expression systems can vary by lot. Contact Aladdin Scientific customer support for detailed specifications if needed.

How should I validate the activity of Recombinant Human CA5A Protein upon receipt?

Upon receipt, perform a quality check by measuring protein concentration and, if applicable, running an SDS-PAGE or Western blot to confirm molecular weight and purity. For functional validation, use a standard carbonic anhydrase activity assay (e.g., the pNPA esterase assay or stopped-flow CO₂ hydration assay). Compare results to the activity data reported on the CoA.

References

  1. Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nature Reviews Drug Discovery. 2008;7(2):168–181. doi:10.1038/nrd2467
  2. Hewett-Emmett D, Tashian RE. Functional diversity, conservation, and convergence in the evolution of the alpha-, beta-, and gamma-carbonic anhydrase gene families. Molecular Phylogenetics and Evolution. 1996;5(1):50–77. doi:10.1006/mpev.1996.0006
  3. Shah GN, Hewett-Emmett D, Grubb JH, et al. Mitochondrial carbonic anhydrase CA VB: differences in tissue distribution and pattern of evolution from CA VA suggest distinct physiological roles. Proceedings of the National Academy of Sciences. 2000;97(4):1677–1682. doi:10.1073/pnas.97.4.1677
  4. Aladdin Scientific. Recombinant Human CA5A Protein, SKU: rp365592. Product Datasheet and Certificate of Analysis. Aladdin Scientific; [current lot].

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

目录: 实验方案(Protocols)

Da — 若无特别说明,分子量单位默认为道尔顿。   Mw — 重均分子量。   Mn — 数均分子量。

产品仅供科研与开发使用,不用于人体、动物、诊断或治疗。

引用本文

阿拉丁科学.《Recombinant Human CA5A Protein: Handling & Usage Protocol》. 阿拉丁知识库,更新于 2026年10月28日。 https://www.aladdin-e.com/zh_cn/faqs/recombinant-human-ca5a-protein-handling-usage-protocol-en.html
这篇文章对您有帮助吗? Yes No 有 1 人觉得有帮助